Abstract
The effects of oral treatment with coenzyme Q10 (120 mg/d) were compared for 28 days in 73 (intervention group A) and 71 (placebo group B) patients with acute myocardial infarction (AMI). After treatment, angina pectoris (9.5 vs. 28.1), total arrhythmias (9.5% vs. 25.3%), and poor left ventricular function (8.2% vs. 22.5%) were significantly (P < 0.05) reduced in the coenzyme Q group than placebo group. Total cardiac events, including cardiac deaths and nonfatal infarction, were also significantly reduced in the coenzyme Q10 group compared with the placebo group (15.0% vs. 30.9%, P < 0.02). The extent of cardiac disease, elevation in cardiac enzymes, and oxidative stress at entry to the study were comparable between the two groups. Lipid peroxides, diene conjugates, and malondialdehyde, which are indicators of oxidative stress, showed a greater reduction in the treatment group than in the placebo group. The antioxidants vitamin A, E, and C and beta-carotene, which were lower initially after AMI, increased more in the coenzyme Q10 group than in the placebo group. These findings suggest that coenzyme Q10 can provide rapid protective effects in patients with AMI if administered within 3 days of the onset of symptoms. More studies in a larger number of patients and long-term follow-up are needed to confirm our results.
Similar content being viewed by others
References
Grech ED, Jackson M, Ramsdale DR. Reperfusion injury after acute myocardial infarction. Br Med J 1995;310:477- 478.
Bernier M, Hearse DJ, Manning AS. Reperfusion induced arrhythmias and oxygen derived free radicals. Circ Res 1986;58:331-340.
Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ Res 1981;48:765-776.
Singh RB, Niaz MA, Rastogi S, Sharma JP, Kumar R, Bishnoi I, Beegom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with suspected acute myocardial infarction. Acta Cardiol 1994;49:441-452.
Wilkinson P, Sayer J, Laji K, Grundy C, Marchant B, Kopelman P, Timmis AD. Comparison of case fatality in South Asian and white patients after acute myocardial infarction: Observational study. Br Med J 1996;312:1330-1333.
Beyer RE, The participation of coenzyme Q10 in free radical production and antioxidation. Free Radic Biol Med 1990;8: 545-565.
Lenaz G, Battino M. Studies on the role of ubiquinone in the control of the mitochondrial respiratory chain. Free Radic Res Commun, 1990;8:317-327.
Atar D, Mortensen SA, Flachs H, Herzog WR. Coenzyme Q10 protects ischemic myocardium in an open-chest swine model. Clin Investig 1993;71:S 103-111.
Herzog WR, Schlossberg ML, Mortensen SA, Serebruany VL. Dietary supplementation with coenzyme Q10 reduces platelet aggregability in swine Coenzyme Q. Res Biol Med 1995;3:5-8.
Serebruany VL, Ordonez JV, Herzog WR, Morten R, Mortensen SA, Folkers K, Gurbel PA. Dietary coenzyme Q10 supplementation alters platelet size and inhibits human Vitronectin (CDSI/CD61) receptor expression. J Cardiovasc Pharmacol 1997;29:16-22.
Battino M, Fato R, Lenaz G. Coenzyme Q10 can control the efficiency of oxidative phosphorylation. Int J Tissue React 1990;12:137-144.
Singh RB, Niaz MA, Rastogi V, Rastogi SS. Coenzyme Q in cardiovascular disease. J Assoc Physiol India 1998;46: 299-306.
Kamikawa T, Kobayashi A, Yamashita T, Hayashi H, Yamasaki N. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985;56:247-257.
Mazzola C, Guffanti EE, Vaccarella A, Meregalli M, Colmago R, Ferrario N, Cantoni V, Marcherri G. Noninvasive assessment of coenzyme Q10 in patients with chronic stable effort angina and moderate heart failure. Curr Ther Res 1987;41: 923-930.
Hofman-Bang C, Rehnqvist N, Swedberg K, Astrom H. Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. J Am Coll Cardiol 1992;19(Suppl.):774-776.
Takasawa K, Fuse K, Konishi T, Watanabe Y. Prevention of premature ventricular contractions with coenzyme Q10 after coronary artery bypass grafting. In: Folkers K, Littami GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Vol. 6, Amsterdam: Elsevier 1991:357-359.
World Health Organization Myocardial Infarction Community Registers Copenhagen. World Health Organization, 1976.
Brubacher G, Vuillenmier JP, Incurtis HC, Roth M, eds. Vitamin C: Clinical Biochemistry, Principles and Methods, Vol. 2. Berlin: de Gruyter, 1974:989-997.
Vuilleumier JP, Keller HE, Gysel D, Hunziker F. Clinical chemical methods for the routine assessment of the vitamin status in human population. Part 1. The fat soluble vitamins A, E and beta-carotene. Int J Vit Nutr Res 1983;58:265-272.
Esterbauer H, Cheeseman KH. Determination of aldehyde peroxidation products malonyldialdehyde and 4 hydroxynonenal. Method Enzymol 1990;186:407-421.
Niato C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Am NY Acad Sci 1993; 676:27-45.
Lunec J, Hallovan SP, White AG, Dormandy TL. Free radical oxidation (peroxidation) products in serum and synovial fluids in rheumatoid arthritis. J Rheumatol 1981:8:233-245.
Schardr F, Welzel D, Schess W, Toda K. Effect of coenzyme Q10 on ischemia-induced ST-segment depression: A double blind, placebo controlled crossover study. In: Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q10, Vol. 5. Amsterdam: Elsevier, 1986:385-394.
Rosi E, Lombardo A, Testa M, et al. Coenzyme Q10 in ischaemic cardiopathy. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6. Amsterdam: Elsevier, 1991:321-326.
Wilson MF, Frishman WH, Giles T, Sethi G, Greenberg SM, Brackett DJ. Coenzyme Q10 therapy and exercise duration in stable angina. In: Folkers K, Littami GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6. Amsterdam: Elsevier, 1991:339-348.
Kuklinski B, Weissenbacher E, Fahnrich A. Coenzyme Q10 and antioxidants in acute myocardial infarction. Mol Aspect Med 1994:15(Suppl.):143-147.
Barbiroli B, Frassineti C, Martinelli P, Iotti S, Lodi R, Cortelli P, Montagna P. Coenzyme Q10 improves mitochondrial respiration in patients with mitrochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell Mol Biol 1997:43:741-749.
Yoshida T, Maulik G, Bagchi D, Dash SK, Engelman RM, Das DK. Increased myocardial tolerance to ischemia-reperfusion injury by feeding pigs with coenzyme Q10. In: Das DK, Engelman R, Cherian KM, eds. Myocardial Preservation, Preconditioning and Adaptation. Ann NY Acad Sci 1996:793:414-419.
Kontush A, Reich A, Baum K, Spranger T, Finckh B, Kohlschutter A, Beisiegel U. Plasma ubiquinol is decreased in patients with hyperlipidemia. Atherosclerosis 1997:129: 119-126.
Yokoyama H, Lingle DM, Crestanello JA, et al. Coenzyme Q10 protects coronary endothelial function from ischaemia reperfusion injury via an antioxidant effect. Surgery 1996; 120:189-196.
Kagan V, Packer L. Electron transport regenerates vitamin E in mitochandria and microsomes via ubiquinone: An antioxidant aduct. In: Corogni F, Banni S, Desai MA, Rice-Evans C, eds. Free Radicals and Antioxidants and Nutrition. London: Richelieu Press, 1993:27-36.
Baggio G, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. Mol Aspects Med 1994;15(Suppl.):287-294.
Karlsson J, Lin L, Gunnes S, Sylven C, Astrom H, Jansson E, Semb B. Muscle characteristics in effort angina before and after CABG. Can J Cardiol 1997;13:577-582.
Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997:18(Suppl.):159-168.
Chopra RK, Goldman R, Sinatra ST, Bhagvan HN. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vit Nutr Res 1998;68:109-113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, R.B., Wander, G.S., Rastogi, A. et al. Randomized, Double-Blind Placebo-Controlled Trial of Coenzyme Q10 in Patients with Acute Myocardial Infarction. Cardiovasc Drugs Ther 12, 347–353 (1998). https://doi.org/10.1023/A:1007764616025
Issue Date:
DOI: https://doi.org/10.1023/A:1007764616025